JPRN-UMIN000010578
已完成
未知
Study of efficacy of aflibercept in neovascular age-related macular degeneration (wAMD) with refractory of ranibizumab - Study of aflibercept in wAMD with refractory of ranibizumab
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 50 人2013年4月26日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Age-related macular degeneration
- 发起方
- agoya City University Graduate School of Medical Sciences
- 入组人数
- 50
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\) Greatest Linear Dimension (GLD) of the total lesion area \<12 Macular Photocoagulation Study Disc Areas 2\) Prior treatment with photodynamic therapy (PDT) within the past 3 months or more than 4 prior PDT treatment 3\) Presence of RPE tears, or subretinal hemorrhage, scar or macular fibrosis (\>50% lesion area area) 4\) Prior treatment with aflibercept 5\) Prior treatment with triamcinolone within 6 months 6\) Prior treatment with dexamethasone within 30 days 7\) Intraocular surgery within 6 months, vitrectomy surgery, submacular surgery, or other surgical intervention for AMD 8\) Active intraocular inflammation 9\) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products
结局指标
主要结局
未指定
相似试验
已完成
不适用
Study of efficacy of aflibercept in neovascular age-related macular degeneration (wAMD) with non-responder of ranibizumabAge-related macular degenerationJPRN-UMIN000010577agoya City University Graduate School of Medical Sciences50
已完成
不适用
Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular DegenerationNeovascular Age-related Macular DegenerationNCT03509623University Hospital of Patras47
进行中（未招募）
1 期
Switching to aflibercept in patients with wet AMD not responding to anti-VEGF treatment.eovascular Age-related macular degenerationTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-001208-12-NLRadboud University Nijmegen Medical Centre20
已完成
4 期
Switching to aflibercept in patients with neovascular AMD not responding to anti-VEGF treatment.age-related macular degenerationmacular degeneration10047060NL-OMON38763niversitair Medisch Centrum Sint Radboud20
已完成
不适用
Overstappen op aflibercept bij patiënten die niet reageren op anti-VEGF therapieneovascular age-related macular degeneration, natte leeftijdsgebonden maculadegeneratieNL-OMON19994Prof. Dr. C.B. HoyngRadboud University Nijmegen Medical Centre, Ophthalmology Department20